Lupus Nephritis Care Pathway

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2026 to Oct 14, 2026
    • Eligibility criteria expanded, about 8 words
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Duke University
457 trials monitored
See 58 trials at risk
Lupus (SLE)
667 trials monitored
See 27 trials at risk
The purpose of this study is to evaluate an approach to managing patients with lupus nephritis called the Lupus Nephritis (LN) Pathway among approximately 25 patients. Activities include answering surveys and participating in an interview. Objectives include: 1) Assess feasibility and acceptability of the LN Care Pathway, 2) evaluate user experiences to identify opportunities for improvement, and 3) explore the preliminary effect of this pathway on medication adherence and clinical outcomes.
Trial Details
NCT Number NCT07783152
Lead Sponsor Duke University
Collaborators: Rheumatology Research Foundation
Conditions
(from sponsor)		 Lupus Nephritis (LN)
Related terms Lupus Nephritis
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov